Similar medications and substitutes for LINVOSELTAMAB-GCPT
In short: Lynozyfic (LINVOSELTAMAB-GCPT) belongs to the Bispecific B Cell Maturation Antigen-directed CD3 T Cell Engager class. The medications listed below either share that mechanism of action or have been clinically validated as substitutes when Lynozyfic is unsuitable due to side effects, cost, availability, or contraindications.
No alternatives are listed for Lynozyfic in our database yet. Browse the full medicine index or consult your pharmacist for substitution advice.